Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort …
…, S Assawakosri, S Kanokudom… - Human vaccines & …, 2022 - Taylor & Francis
In light of intermittent supply shortages of individual vaccines and evidence of rare but serious
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
adverse events after vaccination, heterologous regimens for COVID-19 vaccines have …
[HTML][HTML] Safety and immunogenicity of the third booster dose with inactivated, viral vector, and mRNA COVID-19 vaccines in fully immunized healthy adults with …
S Kanokudom, S Assawakosri, N Suntronwong… - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has become a severe healthcare
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
problem worldwide since the first outbreak in late December 2019. Currently, the COVID-19 …
Neutralizing activities against the Omicron variant after a heterologous booster in healthy adults receiving two doses of CoronaVac vaccination
S Assawakosri, S Kanokudom… - The Journal of …, 2022 - academic.oup.com
Background The use of an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
vaccine (CoronaVac) against SARS-CoV-2 is implemented worldwide. However, …
Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
…, H Phowatthanasathian, S Assawakosri, S Kanokudom… - Vaccine, 2022 - Elsevier
In June 2021, Thailand was hit by the delta variant of SARS-CoV-2 resulting in the biggest
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
wave of COVID-19. Due to the widespread delta variant, more than 600 healthcare workers …
Effects of boosted mRNA and adenoviral‐vectored vaccines on immune responses to omicron BA. 1 and BA. 2 following the heterologous CoronaVac/AZD1222 …
N Suntronwong, S Kanokudom… - Journal of Medical …, 2022 - Wiley Online Library
The coronavirus 2019 omicron variant has surged rapidly and raises concerns about immune
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
evasion even in individuals with complete vaccination, because it harbors mutations. Here …
[HTML][HTML] Immunogenicity following two doses of the BBIBP-CorV vaccine and a third booster dose with a viral vector and mRNA COVID-19 vaccines against delta and …
J Chansaenroj, N Suntronwong, S Kanokudom… - Vaccines, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) booster vaccination is being comprehensively
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
evaluated globally due to waning immunity and the emergence of new severe acute respiratory …
miR-21 promotes dengue virus serotype 2 replication in HepG2 cells
S Kanokudom, T Vilaivan, N Wikan, C Thepparit… - Antiviral Research, 2017 - Elsevier
Infection with the mosquito transmitted dengue virus (DENV) remains a significant worldwide
public health problem. While the majority of infections are asymptomatic, infection can …
public health problem. While the majority of infections are asymptomatic, infection can …
[HTML][HTML] Rapid detection of extended spectrum β-lactamase producing Escherichia coli isolated from fresh pork meat and pig cecum samples using multiplex …
S Kanokudom, T Assawakongkarat, Y Akeda… - PLoS …, 2021 - journals.plos.org
The emergence and dissemination of extended-spectrum β-lactamase (ESBL)-producing
Escherichia coli is a global health issue. Food-producing animals, including pigs, are …
Escherichia coli is a global health issue. Food-producing animals, including pigs, are …
[HTML][HTML] COVID-19 breakthrough infection after inactivated vaccine induced robust antibody responses and cross-neutralization of SARS-CoV-2 variants, but less …
…, T Thongmee, P Vichaiwattana, S Kanokudom… - Vaccines, 2022 - mdpi.com
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
and the waning of immunity in vaccinated individuals is resulting in increased numbers of …
[HTML][HTML] Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens
S Kanokudom, J Chansaenroj, N Suntronwong… - International Journal of …, 2023 - Elsevier
Objectives To report the safety and immunogenicity profile of a protein subunit vaccine (Covovax
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
TM ) given as a third (booster) dose to individuals primed with different primary vaccine …
